Semaglutide and tirzepatide are widely prescribed for weight management and type 2 diabetes, and most people take them alongside other medications, whether for blood pressure, mood, birth control, or a chronic condition like diabetes itself. Like any medication, a GLP-1 receptor agonist can interact with other drugs, and understanding the main categories of interaction can help you have a more useful conversation with your prescribing clinician.
This article is patient education, not medical advice. It does not create a doctor-patient relationship and is not a substitute for an individualized review of your medications by a licensed clinician who knows your full health history.
Why GLP-1 medications can interact with other things you take
Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™) are effective, extensively studied medications, and for most people, taking another medication alongside one of them is not a reason to avoid treatment. It is, however, a reason to disclose your full medication list to the clinician managing your care, so any interaction that does matter for you specifically can be identified and managed rather than discovered after the fact.
Unlike drugs that interact through many separate chemical pathways, most of what clinicians watch for with GLP-1 medications traces back to one shared mechanism. That makes the topic more manageable to understand than it might first appear, even though the list of medications it can touch is broad. This is also why disclosure matters more on telehealth: without a pharmacist asking what else is in your bag, the responsibility for an accurate, current list shifts more squarely onto you and your clinician's intake process.
Delayed gastric emptying: the mechanism behind most interactions
GLP-1 receptor agonists slow gastric emptying, the rate at which the stomach releases its contents into the small intestine. This is part of how these medications help people feel full for longer and eat less, and it is also why nausea and fullness are among the most common early side effects. The same slowing effect can change how quickly other oral medications dissolve and are absorbed into the bloodstream, since most oral drugs rely on reaching the small intestine to be absorbed efficiently.
For most oral medications, this shift in absorption timing is modest and does not require any specific action; the body still absorbs the medication, just somewhat more slowly than it would otherwise. For a smaller group of medications, the timing of absorption or the total amount absorbed matters enough that it is worth a clinician's attention. The sections below cover the categories that come up most often. Gastric emptying also tends to slow more noticeably early in treatment and after each dose increase, which is why clinicians pay closer attention to medication timing around those points rather than only at the first visit.
| Category | Example | Why it comes up |
|---|---|---|
| Oral hormonal contraceptives | Combination birth control pills | Delayed absorption addressed specifically in tirzepatide's FDA labeling |
| Insulin and insulin secretagogues | Insulin, sulfonylureas | Combined use raises hypoglycemia risk; dose adjustment may be needed |
| Narrow therapeutic index drugs | Warfarin and similar medications | Small absorption changes can matter more; closer monitoring may be appropriate |
| OTC medications and supplements | Pain relievers, herbal supplements | Often overlooked, but worth disclosing along with prescription drugs |
Oral hormonal birth control: what tirzepatide's labeling says
Of all the interactions discussed with GLP-1 medications, this is the one with the clearest, most specific guidance from the FDA. Tirzepatide's prescribing information, which covers both Mounjaro® and Zepbound™, addresses oral hormonal contraceptives directly: because delayed gastric emptying can reduce how well an oral contraceptive pill is absorbed, the labeling advises switching to a non-oral contraceptive method, or adding a barrier method, for a period of time around starting tirzepatide and again after each dose increase.
This guidance is specific to tirzepatide's own FDA labeling. If you use semaglutide and take an oral contraceptive, it is still worth raising the topic with your prescribing clinician, since the underlying mechanism, delayed gastric emptying, is shared across this medication class even where labeling language differs by product. Non-oral contraceptive options that aren't affected by gastric emptying, such as an intrauterine device, an implant, or an injection, sidestep this concern entirely, which is one reason some clinicians discuss these alternatives with patients starting treatment who currently rely on the pill. Choosing a contraceptive method is its own decision, though, and one to make with the clinician who manages your reproductive health.
Insulin and other diabetes medications: the hypoglycemia risk
For people being treated for type 2 diabetes, combining a GLP-1 medication with insulin or an insulin secretagogue, such as a sulfonylurea, increases the risk of hypoglycemia, or blood sugar dropping too low. This isn't a reason to avoid the combination, which is common and often clinically appropriate, but it is a reason for active management. FDA labeling notes that a clinician may need to lower the dose of insulin or the secretagogue when starting a GLP-1 medication, precisely because the GLP-1 medication itself also helps lower blood sugar, and the combined effect can be stronger than either medication alone.
If you use insulin or a sulfonylurea, your clinician will likely want to check blood sugar more closely during the first weeks after starting or adjusting a GLP-1 medication, and may walk you through the signs of hypoglycemia, such as shakiness, sweating, confusion, or lightheadedness, so you know what to watch for and when to act. This category is a good reminder that the mechanism described earlier, delayed gastric emptying, isn't the only pathway worth knowing about: the insulin interaction is about two medications that both lower blood sugar working together more powerfully, not about absorption timing at all.
Blood thinners and other narrow-therapeutic-index medications
Because delayed gastric emptying can shift how quickly any oral medication is absorbed, clinicians pay particular attention to medications with a narrow therapeutic index, meaning the gap between an effective dose and a harmful one is small. Warfarin is a commonly cited example. A shift in absorption timing that would be inconsequential for most medications can matter more for a drug like this, so closer monitoring, such as more frequent lab checks, may be appropriate when starting or adjusting a GLP-1 medication alongside it.
This is a conversation to have with the clinician managing the narrow-therapeutic-index medication as well as the one prescribing your GLP-1 treatment, particularly if those are two different providers. Making sure both have your complete, current medication list is what allows this kind of coordination to happen. If you're also planning a surgery or procedure while on treatment, our guide to GLP-1 medications before surgery covers a related set of timing questions that often come up for the same patients.
Over-the-counter medications and supplements
It's easy to think of "medications" as only the prescriptions in your medicine cabinet, but over-the-counter drugs and supplements count too. Common pain relievers, allergy medications, antacids, and herbal or vitamin supplements can all, in principle, be affected by the same delayed-absorption mechanism, even if most don't require any specific action. The safest approach is to disclose everything you take regularly, not just prescriptions, so your clinician can flag anything that actually needs attention rather than you having to guess which products are worth mentioning.
This also applies to products people don't always think of as "medications," such as daily multivitamins, fish oil, melatonin, or herbal supplements, which can carry their own interaction risks independent of anything related to GLP-1 medications. It's also worth remembering that starting a GLP-1 medication isn't a reason to stop any other medication on your own; any change to an existing prescription should go through the clinician who prescribed it, not be decided independently based on something you've read, including this article.
What to bring to your clinician visit
A few minutes of preparation before a visit, whether it's your first evaluation or a routine follow-up, makes it much easier for your clinician to spot anything that matters. Consider bringing or listing:
- Every prescription medication you currently take, including the dose and how often you take it.
- Over-the-counter medications you take regularly, such as pain relievers, antihistamines, or antacids.
- Supplements and herbal products, even ones you consider unrelated to any medical condition.
- Your contraceptive method, if applicable, so your clinician can flag whether a backup method is worth discussing.
- Any upcoming procedures or surgeries, since these can involve their own timing questions around GLP-1 treatment.
- Any recent changes to your medication list since your last visit, even ones that feel minor.
If you're also navigating a pregnancy timeline alongside birth control questions, our article on GLP-1 medications and pregnancy planning covers that topic in more depth. None of this needs to happen in a single conversation: most clinicians review your medication list at intake and again at follow-up visits, especially around dose changes, so there are repeated opportunities to raise something that's changed since your last visit.
The bottom line
Most interactions between GLP-1 medications and other drugs trace back to one mechanism, delayed gastric emptying, and most of them don't require you to avoid a combination altogether. A handful of categories, oral birth control, insulin and related diabetes medications, and narrow-therapeutic-index drugs like warfarin, warrant a more specific conversation with your clinician, while over-the-counter medications and supplements are worth mentioning even when they seem unrelated. The most useful thing you can do is keep your full medication list current and share it honestly at every visit, rather than deciding on your own which medications are worth mentioning. If you're weighing semaglutide against tirzepatide more broadly, our comparison of the two medications is a good next read, as is our overview of GLP-1 side effects.
You can find more articles like this one in our Weight Management section.
Important Safety Information
Indication. Semaglutide is FDA-approved as Ozempic® for type 2 diabetes and as Wegovy® for chronic weight management; tirzepatide is FDA-approved as Mounjaro® for type 2 diabetes and as Zepbound™ for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity, each used alongside a reduced-calorie diet and increased physical activity as appropriate to the approved use. Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality; they may be prescribed by an independent licensed physician when clinically appropriate.
Common side effects. The most commonly reported side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. These are often mild and tend to ease over time, particularly as the dose is increased gradually.
Warnings. These medications carry a boxed warning regarding thyroid C-cell tumors seen in rodent studies and should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your provider about every prescription medication, over-the-counter medication, and supplement you take, including oral contraceptives, insulin or other diabetes medications, and blood thinners, as well as any history of pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, or if you are pregnant, planning to become pregnant, or breastfeeding.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
Can I take other medications while using semaglutide or tirzepatide?
In most cases, yes. Many people take semaglutide or tirzepatide alongside other medications without issue. The key is disclosing your complete, current medication list, including over-the-counter drugs and supplements, to your prescribing clinician so they can identify anything that needs specific attention.
Does tirzepatide affect how well birth control pills work?
Tirzepatide's FDA labeling specifically addresses this. Because tirzepatide delays gastric emptying, it can reduce how well an oral contraceptive is absorbed, and the labeling advises switching to a non-oral contraceptive method or adding a barrier method for a period of time around starting treatment and after each dose increase. Talk to your clinician about what this means for your specific situation.
Is it dangerous to combine a GLP-1 medication with insulin?
It isn't inherently dangerous, but it does raise the risk of hypoglycemia, or blood sugar dropping too low, since both medications lower blood sugar. Your clinician may need to adjust your insulin or sulfonylurea dose when you start a GLP-1 medication, and may ask you to check blood sugar more often during that adjustment period.
Should I tell my clinician about supplements and over-the-counter medications too?
Yes. Over-the-counter drugs and supplements can, in principle, be affected by the same delayed-absorption mechanism as prescription medications. Disclosing everything you take regularly, not just prescriptions, gives your clinician the full picture needed to flag anything relevant.
What if I'm already taking a blood thinner like warfarin?
Medications with a narrow therapeutic index, where the gap between an effective dose and a harmful one is small, such as warfarin, warrant closer attention when starting a GLP-1 medication. Your clinician may recommend more frequent monitoring during this period. This is a conversation to have with both the clinician managing your blood thinner and the one prescribing your GLP-1 treatment.